Publication | Closed Access

An endogenous pentapeptide acting as a sodium channel blocker in inflammatory autoimmune disorders of the central nervous system

InflammationEndogenous PentapeptideAutoimmune DiseaseMedicineImmunologyNeuropeptide ReceptorNeuropharmacologyAutoimmunityBrain-immune InteractionSodium Channel BlockerCentral Nervous SystemPharmacologyNeuroimmunologyNeuropeptidesNeuroinflammation